Skip to content


Utilising the DeliverEXTM platform, Evox is developing a proprietary pipeline of exosome-based therapeutics for treating life-threatening rare diseases. These therapeutics will have a transformative impact on the lives of patients suffering from rare diseases where there are currently few, if any, treatment options.

Evox Pipeline

With an initial focus on rare disease, we are exploring the significant potential and versatility of exosome therapeutics in other disease areas. With a proven approach to engineering exosomes, we are exploring therapeutic possibilities where tissue targeting and loading of different drug cargoes into exosomes can have a transformative effect on hitherto untreated diseases.

We use cookies to give you the best experience of using this website. By continuing to use this site, you accept our use of cookies. Please read our Cookie Policy for more information.